Adamant Biomedical Investments’s Tenet Healthcare THC Stock Holding History

Adamant Biomedical Investments’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$1.77M	Buy	+35,000	New	+$1.83M	0.42%	69

Other funds holding THC

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adamant Biomedical Investments's THC Position: Q4 2014 in Review

Adamant Biomedical Investments opened a new position in Tenet Healthcare (THC) in Q4 2014: 35,000 shares worth $1.77M. The stake represents 0.42% of the portfolio and ranks #69 among its holdings.

325 funds tracked by Wall St. Rank hold THC as of Q4 2014.

Adamant Biomedical Investments held 35,000 shares of Tenet Healthcare worth $1.77M as of Q4 2014.
Tenet Healthcare was a new Adamant Biomedical Investments position in Q4 2014.
Tenet Healthcare made up 0.42% of Adamant Biomedical Investments's portfolio in Q4 2014, its #69 holding.
325 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.